Journal of Medical Economics
Volume 24, 2021 - Issue 1
Cardiovascular
Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States
Sneha S. Jaina New York-Presbyterian/Columbia University Medical Center, New York, NY, USA
https://orcid.org/0000-0002-0592-1453
https://orcid.org/0000-0002-0592-1453, , Jipan Xiec Analysis Group, Inc., Los Angeles, CA, USAhttps://orcid.org/0000-0001-5937-0936
https://orcid.org/0000-0001-5937-0936, , , Jay M. Edelbergb MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USAhttps://orcid.org/0000-0001-9591-0995
https://orcid.org/0000-0001-9591-0995, , John A. Spertuse Biomedical and Health Informatics, Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USA;f Mid America Heart Institute, Kansas City, MO, USAhttps://orcid.org/0000-0002-2839-2611
https://orcid.org/0000-0002-2839-2611 & David J. Coheng St. Francis Hospital, Roslyn, NY, USA;h Cardiovascular Research Foundation, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0001-9163-724X
https://orcid.org/0000-0001-9163-724X show all